What Is Biohaven Ltd. (BHVN) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Biohaven Ltd.'s intrinsic value is estimated at a composite fair value of $10.73. Trading at $14.87, the stock is approaching fair value or slight overvaluation (implied return of -27.9%), as 4 of 6 models suggest limited further upside. Model dispersion is worth noting: Sentiment SOTP targets $20.66 (+39.0%), versus Bayesian DCF at $2.31 (-84.5%). This +123.4% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About BHVN?
6 of 13 models are currently active for BHVN. Of these, 2 models suggest upside while 4 models suggest overvaluation. The Bayesian DCF estimates BHVN's intrinsic value at $2.31, implying -84.5% downside from the current price. See which stocks rank higher →
How Does BHVN Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, BHVN ranks #351 by Quality of Company score. CirclFi's QOC score of 3.8/10 evaluates 32 fundamental signals. A score of 3.8 signals below-average fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
The Pharmaceutical Preparations sector introduces analytical considerations specific to biopharma enterprise businesses. For Biohaven Ltd., metrics like biosimilar competition timeline provide important context that general-purpose valuation models may underweight.
Is BHVN a Value Trap?
CirclFi's Value Trap algorithm assigns BHVN a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
6 of 13 models are active for Biohaven Ltd.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Biohaven Ltd. scores 3.8 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +123.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every BHVN valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across BHVN's 6 active models, average confidence is 23%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad